Roumell withdraws nomination of Hellerman, supports management's efforts PR Newswire CHEVY CHASE, Md., May 21, 2014 CHEVY CHASE, Md., May 21, 2014 /PRNewswire/ -- May 20, 2014 Board of Directors Transcept Pharmaceuticals, Inc. 1003 W. Cutting Blvd. Suite 110 Pt. Richmond, CA 94804 Consistent with our status as a passive shareholder, Roumell Asset Management withdraws the nomination of Gerald Hellerman to the Board. We believe the Company is taking the proper steps to maximize value for shareholders and is diligently and methodically reviewing several potential transactions. Moreover, we applaud the company's recent decision to promptly distribute $25 million in cash to shareholders. Regards, James C. Roumell SOURCE Roumell Asset Management, LLC Contact: Roumell Asset Management, LLC, +1-301-656-8500
Roumell withdraws nomination of Hellerman, supports management's efforts
Press spacebar to pause and continue. Press esc to stop.